PubMed:22543025 / 441-884
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 257-270 | https://glytoucan.org/Structures/Glycans/G00068MO | denotes | blood group H |
T4 | 257-270 | https://glytoucan.org/Structures/Glycans/G43391VM | denotes | blood group H |
T5 | 257-270 | https://glytoucan.org/Structures/Glycans/G50899UD | denotes | blood group H |
T6 | 342-361 | https://glytoucan.org/Structures/Glycans/G00055MO | denotes | N-acetyllactosamine |
T7 | 363-371 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | lacdiNAc |
T8 | 363-371 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | lacdiNAc |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T3 | 257-270 | Glycan_Motif | denotes | blood group H | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G50899UD|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43391VM|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00068MO |
T6 | 342-361 | Glycan_Motif | denotes | N-acetyllactosamine | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00055MO |
T7 | 363-371 | Glycan_Motif | denotes | lacdiNAc | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G31736BK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00057MO |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 257-270 | https://glytoucan.org/Structures/Glycans/G00068MO | denotes | blood group H |
T4 | 257-270 | https://glytoucan.org/Structures/Glycans/G43391VM | denotes | blood group H |
T5 | 257-270 | https://glytoucan.org/Structures/Glycans/G50899UD | denotes | blood group H |
T6 | 342-361 | https://glytoucan.org/Structures/Glycans/G00055MO | denotes | N-acetyllactosamine |
T7 | 363-371 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | lacdiNAc |
T8 | 363-371 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | lacdiNAc |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 257-262 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
T3 | 257-262 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T18 | 34-50 | FMAID:196731 | denotes | oligosaccharides |
_T19 | 34-50 | FMAID:82742 | denotes | oligosaccharides |
_T20 | 257-262 | FMAID:256053 | denotes | blood |
_T21 | 342-361 | FMAID:196780 | denotes | N-acetyllactosamine |
_T22 | 342-361 | FMAID:82786 | denotes | N-acetyllactosamine |
_T23 | 409-415 | FMAID:226027 | denotes | branch |
_T24 | 409-415 | FMAID:226028 | denotes | branch |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 57-59 | http://www.uniprot.org/uniprot/Q99707 | denotes | MS |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 57-59 | http://www.uniprot.org/uniprot/A6H5Y3 | denotes | MS |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 97-110 | http://purl.bioontology.org/ontology/NCBITAXON/1113441 | denotes | heterogeneous |
T5 | 97-110 | http://purl.bioontology.org/ontology/NCBITAXON/691256 | denotes | heterogeneous |
T6 | 139-145 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T7 | 263-268 | http://purl.bioontology.org/ontology/STY/T096 | denotes | group |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 182-192 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialylated |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 257-262 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 139-145 | HP_0002664 | denotes | cancer |
GlycoBiology-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 257-262 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
T3 | 257-262 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
GlyTouCan-IUPAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
GlycanIUPAC_T1 | 436-442 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
GlycanIUPAC_T2 | 436-442 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
GlycanIUPAC_T3 | 436-442 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
GlycanIUPAC_T4 | 436-442 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
GlycanIUPAC_T5 | 436-442 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
GlycanIUPAC_T6 | 436-442 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
GlycanIUPAC_T7 | 436-442 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
GlycanIUPAC_T8 | 436-442 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
GlycanIUPAC_T9 | 436-442 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
GlycanIUPAC_T10 | 436-442 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
GlycanIUPAC_T11 | 436-442 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
GlycanIUPAC_T12 | 436-442 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
GlycanIUPAC_T13 | 436-442 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
GlycanIUPAC_T14 | 436-442 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
GlycanIUPAC_T15 | 436-442 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
GlycanIUPAC_T16 | 436-442 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
GlycanIUPAC_T17 | 436-442 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
GlycanIUPAC_T18 | 436-442 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
GlycanIUPAC_T19 | 436-442 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
GlycanIUPAC_T20 | 436-442 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
GlycanIUPAC_T21 | 436-442 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
GlycanIUPAC_T22 | 436-442 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
GlycanIUPAC_T23 | 436-442 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
GlycoBiology-Motifs
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 257-268 | http://rdf.glycoinfo.org/glycan/G00066MO | denotes | blood group |
T2 | 257-270 | http://rdf.glycoinfo.org/glycan/G00068MO | denotes | blood group H |
T3 | 363-371 | http://rdf.glycoinfo.org/glycan/G00057MO | denotes | lacdiNAc |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 257-262 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 139-145 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T2 | 257-262 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 139-145 | Phenotype | denotes | cancer | HP:0002664 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 378-384 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T2 | 436-442 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 139-145 | Phenotype | denotes | cancer | HP:0002664 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 139-145 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T4 | 146-153 | OrganismTaxon | denotes | patient | 9606 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T3 | 257-262 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T2 | 257-262 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-443 | Sentence | denotes | Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 378-384 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T2 | 436-442 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T4 | 146-153 | OrganismTaxon | denotes | patient | 9606 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T3 | 257-262 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |